martes, 16 de julio de 2013

USA: Quién paga por esto...?



The Obama administration issued a new rule this month that requires the makers of prescription drugs and other medical products to disclose what they pay doctors for various purposes, like consulting or speaking on behalf of the manufacturer. This overdue rule adds much-needed weight to previous, more limited disclosure requirements.
The goal is to let the public know about payments that might lead doctors to prescribe treatments that benefit them financially without necessarily benefiting patients.
This information will allow patients and their families to check whether their own doctors are receiving payments and to see if those financial connections affect a doctor’s recommendation for a particular treatment or device. (Más)

Ver también:

Derrochando...millones. ($760 million entre 2009 y 2011) (III)

Publicar un comentario en la entrada